Stockscreener 앱 받기
4.99
8.01%
0.37
시간 외 거래:
4.75
-0.24
-4.81%
전일 마감가:
$4.62
열려 있는:
$4.6
하루 거래량:
30,206
Relative Volume:
0.18
시가총액:
$9.03M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-9.27%
1개월 성능:
+8.48%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$4.60
$5.06
1주일 범위
$4.00
$5.50
52주 변동 폭
$3.50
$8.86
Quantum Biopharma Ltd Stock (QNTM) Company Profile
명칭
Quantum Biopharma Ltd
전화
-
주소
-
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Quantum BioPharma initiates phase 1 multiple sclerosis trial By Investing.com - Investing.com Canada
Quantum BioPharma sues CIBC and RBC seeking $700M in damages - MSN
Quantum BioPharma initiates phase 1 multiple sclerosis trial - Investing.com
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia - AccessWire
InvestmentPitch Media Video Discusses FSD Pharma's New OTCQB Symbol and Appointment of Former U.S. Congressman Stephen Buyer to its Board of DirectorsVideo Available on Investmentpitch.com - Marketscreener.com
Christian Attar Files Market Manipulation Case On Behalf of Quantum Biopharma - Marketscreener.com
Freedman Normand Friedland Files Market Manipulation Case On Behalf of Quantum Biopharma - PR Newswire
Quantum BioPharma Ltd - Stockhouse Publishing
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH - Marketscreener.com
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spo - AccessWire
Quantum BioPharma alleges major market manipulation By Investing.com - Investing.com Australia
Quantum BioPharma sues over alleged stock spoofing - The Globe and Mail
Quantum BioPharma sues CIBC and RBC seeking $700M in damages | 2024-10-21 | Investing News - Stockhouse Publishing
Quantum BioPharma alleges major market manipulation - Investing.com
Quantum BioPharma (Nasdaq: QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing - Chronicle-Tribune
Quantum BioPharma (QNTM) Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700M - StreetInsider.com
Quantum BioPharma Ltd. (NASDAQ: QNTM): Pioneering Alcohol Metabolism Support with Unbuzzd - openPR
Kairos Pharma (NYSEAmerican: KAPA): Advancing New Strategies to Overcome Cancer Treatment Challenges - openPR
Quantum BioPharma Expands Market for Alcohol Metabolism Product Unbuzzd - Vancity Buzz
Celly Nu secures distribution for alcohol metabolism drink By Investing.com - Investing.com South Africa
Celly Nu secures distribution deal in the Caribbean By Investing.com - Investing.com South Africa
Celly Nu secures distribution deal in the Caribbean - Investing.com India
Celly Nu secures distribution for alcohol metabolism drink - Investing.com
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and Parts of Central and South America - Newsfile
Quantum BioPharma Ltd. Pharma Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group Across Puerto Rico, the Caribbean, and Parts of Central and South America - WSIL TV
Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America - AccessWire
Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews
Quantum Biopharma Provides Corporate Update - GuruFocus.com
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US - Markets Insider
Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Invesments and Kingswood US - Quantisnow
Investor.News Prepares for the ArcStone-Kingswood Growth Summit 2024 - InvestorNews Inc.
Quantum BioPharma Closes Private Placement Offering - Invezz
QUANTUM BIOPHAR (QNTM) Upgraded to Buy: Here's What You Should Know - MSN
Quantum BioPharma Ltd. announced that it has received CAD 0.000036 million in funding from Fortius Research and Trading Corporation, Xorax Family Trust - Marketscreener.com
Quantum BioPharma to run multiple sclerosis progression study | 2024-09-09 | Investing News - Stockhouse Publishing
Quantum BioPharma partners for multiple sclerosis study - Investing.com
S&P 500 Materials [Sector] (SRMA) QuotePress Release - The Globe and Mail
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease Progression in Patients With Primary Progressive Multiple Sclerosis - Digital Journal
Quantum Biopharma Signs an Agreement With Ingenu CRO to Conduct a Clinical Study to Observe Disease - PharmiWeb.com
The Globe and Mail - The Globe and Mail
ArcanaBio Secures Funding from BioInnovation Institute to Revolutionize Healthcare with new Ultra-Rapid Liquid Biopsy Technology - Via Ritzau
Quantum Biopharma Receives Nasdaq Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement and Completes Debt Settlements - AccessWire
Quantum Biopharma Ltd (QNTM) 재무 분석
Quantum Biopharma Ltd (QNTM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.88%
0.42%
자본화:
|
볼륨(24시간):